Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 18,156
- Companies
- 1,062
- Drugs tracked
- 3,385
Quick answer
NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
ADRENALINE AGUETTANT 1 mg/ml, solution injectable en ampoule
Novo mesto
Cardiorespiratory arrest at birth in full-term newborns
1 trial -
TEMOZOLOMIDE , KEYTRUDA 25 mg/mL concentrate for solution for infusion, saline solution for infusion
Novo mesto
Newly diagnosed Glioblastoma
1 trial -
Tecentriq 840 mg concentrate for solution for infusion
Novo mesto
Metastatic pancreatic ductal adenocarcinoma (mPDAC)
1 trial -
UVEDOSE 100 000 UI, solution buvable en ampoule
Novo mesto
Thyroidectomy is a common operation. Transient postoperative hypocalcemia is the main complication, resulting in clinical discomfort for patients, longer hospital stays and increased perioperative cost. Cholecalciferol is used to supplement vitamin D deficiency. We suppose that systematic pre-operative supplementation with cholecalciferol would allow a faster and more appropriate response to post-operative hypocalcemia
1 trial -
Matched Placebo
Novo mesto
Mechanical allodynia
1 trial -
Product
Novo mesto
Women with an indication for IVF/ICSI
1 trial -
To evaluate the pharmacokinetics and safety of nolasiban
Novo mesto
not applicable (submitted trial is a pharmacokinetic study in healthy subjects)
1 trial -
Paracetamol Biofarm, 500 mg, tabletki, Placebo - Nalgesin forte, Nalgesin Forte, 550 mg, tabletki powlekane
Novo mesto
Knee osteoarthritis
1 trial -
Sorvasta 20 mg filmsko obloลพene tablete, Sorvitimb 20 mg/10 mg filmsko obloลพene tablete, Sorvasta 10 mg filmsko obloลพene tablete, Sorvasta 40 mg filmsko obloลพene tablete, Sorvitimb 40 mg/10 mg filmsko obloลพene tablete
Novo mesto
Hyperlipidaemia
1 trial -
Telmisartan/Amlodipine/Hydrochlorothiazide, Teldipin, 80 mg + 5 mg, tabletki, Telmisartan/Amlodipine/Hydrochlorothiazide, Tamloset 40 mg/5 mg tabletta, Tamloset 80 mg/10 mg tabletta, Telassmo 80 mg/10 mg tablete, Tamloset 80 mg/5 mg tabletta, Teldipin, 80 mg + 10 mg, tabletki, Telassmo 40 mg/5 mg tablete, Telmisartan/Amlodipine/Hydrochlorothiazide, Teldipin, 40 mg + 5 mg, tabletki, Telassmo 80 mg/5 mg tablete
Novo mesto
Arterial hypertension
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources